Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid

BACKGROUND: Staphylococcal infection of the canine epidermis and hair follicle is amongst the commonest reasons for antimicrobial prescribing in small animal veterinary practice. Topical therapy with fusidic acid (FA) is an attractive alternative to systemic therapy based on low minimum inhibitory concentrations (MICs, commonly <0.03 mg/l) documented in canine pathogenic staphylococci, including strains of MRSA and MRSP (methicillin-resistant Staphylococcus aureus and S. pseudintermedius). However, permeation of canine skin by FA has not been evaluated in detail. This study aimed to define the degree and extent of FA permeation in canine skin in vitro from two sites with different hair follicle density following application of a licensed ophthalmic formulation that shares the same vehicle as an FA-betamethasone combination product approved for dermal application in dogs. Topical FA application was modelled using skin held in Franz-type diffusion cells. Concentrations of FA in surface swabs, receptor fluid, and transverse skin sections of defined anatomical depth were determined using high-performance liquid chromatography and ultraviolet (HPLC-UV) analysis. RESULTS: The majority of FA was recovered by surface swabs after 24 h, as expected (mean ± SEM: 76.0 ± 17.0%). FA was detected within 424/470 (90%) groups of serial sections of transversely cryotomed skin containing follicular infundibula, but never in 48/48 (100%) groups of sections containing only deeper follicular structures, nor in receptor fluid, suggesting that FA does not permeate beyond the infundibulum. The FA concentration (mean ± SEM) in the most superficial 240 μm of skin was 2000 ± 815 μg/g. CONCLUSIONS: Topically applied FA can greatly exceed MICs for canine pathogenic staphylococci at the most common sites of infection. Topical FA therapy should now be evaluated using available formulations in vivo as an alternative to systemic therapy for canine superficial bacterial folliculitis.Peer reviewedFinal Published versio

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

Progress of PIP-II Activities at IJCLab

International audienceSince 2018, IJCLab is involved in PIP-II project on the design and development of accelerator components for the SSR2 (Single Spoke Resonator type 2) section of the superconducting linac. First pre-production components have been fabricated, surface processing and cavity qualification in vertical cryostat are on-going. IJCLab has upgraded its facilities by developing a new set-up to perform rotational BCP. The progress of all processing and testing activities for PIP-II project will be reported and, in particular, a dedicated study to qualify removal uniformity compared to static BCP will be presented

Contribution of IN2P3 to PIP-II Project: Plans and Progress

International audienceIJCLab is one of the labs of IN2P3 (National institute of nuclear and particle physics), one of the ten research institutes composing the French National Center for Scientific Research (CNRS). Since 2018, IJCLab has been involved in the PIP-II project, assisting with the design, development, and qualification of accelerator components for the SSR2 (Single Spoke Resonator type 2) section of the superconducting linac. The first pre-production components (cavity, coupler, and tuner) have been fabricated, and some of the first qualification tests have been performed at IJCLab. This paper will summarize the complete scope of IJCLab¿s contributions to PIP-II and give updates on the performances of the first pre-production components